Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 - Ohtori Study Part 2

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056009

Enrollment

2000

Registered

2024-11-01

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus, Hyperglycemia, Hypertension, Hyperlipidemia, Dyslipidemia, Hyperuricemia/gout, Metabolic syndrome, Obesity, Abdominal obesity, Central obesity, Visceral fat, Hepatic steatosis, Chronic kidney disease, Atherosclerosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy men and women over 20 years old

Exclusion criteria

Exclusion criteria: Women who may be pregnant

Design outcomes

Primary

Measure	Time frame
The prevalence and incidence of cardiometabolic disease, including type 2 diabetes, hypertension, obesity, dyslipidemia, metabolic syndrome, ischemic heart disease, cerebrovascular disease, hyperuricemia, and chronic kidney disease.	—

Secondary

Measure	Time frame
Continuous variables that define each endpoint Continuous variables that define each risk factor	—

Countries

Japan

Contacts

Public ContactTomoshige Hayashi

Osaka Metropolitan University Preventive Medicine and Environmental Health, Graduate School of Medicine

thayashi@omu.ac.jp06-6645-3751

Outcome results